10x Genomics (0A88) Risk Analysis
Risk Overview Q2, 2026
Source: the company's latest filing for the period ended Jun 30, 2026, filed Aug 06, 2026
Risk Change Over Time
Risk Highlights Q2, 2026
Risk Word Cloud
Risk Factors Full Breakdown - Total Risks 8
- Share Price & Shareholder Rights - Risk 1Risks related to our Class A common stock
The multi-class structure of our common stock concentrates voting control in the hands of certain stockholders, which may limit the ability of other shareholders to influence corporate decisions. Additionally, sales of a substantial number of shares of our Class A common stock by existing stockholders, insiders or others could cause the market price to decline. The conversion rights associated with our Class B common stock, as well as other structural features of our capital structure, may further affect the market price and liquidity of our Class A common stock, potentially leading to volatility in our stock price and adversely impacting our stockholders’ value.
See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.